FDA Inspection 611515 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 1052094

The FDA completed an inspection of Biomat USA, Inc. on Aug 28, 2009 in Jacksonville, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 28, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Jacksonville, FL (United States)

Citations

IDCFRDescription
25521 CFR 640.31Donor eligibility
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs